Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2

被引:120
作者
Girard, R
Pedron, T
Uematsu, S
Balloy, V
Chignard, M
Akira, S
Chaby, R
机构
[1] Univ Paris 11, Natl Ctr Sci Res, UMR 8619, Endotoxin Grp, Orsay, France
[2] Inst Pasteur, Natl Ctr Sci Res, URA 1961, Paris, France
[3] Inst Pasteur, INSERM, U389, F-75724 Paris, France
[4] Osaka Univ, Microbial Dis Res Inst, Dept Host Defense, Osaka, Japan
[5] Inst Pasteur, INSERM Z485, Unite Associee, Paris, France
关键词
lipopolysaccharide; toll-like receptors; bone marrow; CD14; innate immunity;
D O I
10.1242/jcs.00212
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lipopolysaccharide (LPS) derived from enterobacteria elicit in several cell types cellular responses that are restricted in the use of Toll-like receptor 4 (TLR4) as the principal signal-transducing molecule. A tendency to consider enterobacterial LPS as a prototypic LPS led some authors to present this mechanism as a paradigm accounting for all LPSs in all cell types. However, the structural diversity of LPS does not allow such a general statement. By using LPSs from bacteria that do not belong to the Enterobacteriaceae, we show that in bone marrow cells (BMCs) the LPS of Rhizobium species Sin-1 and of three strains of Legionella pneumophila require TLR2 rather than TLR4 to elicit the expression of CD14. In addition, exposure of BMCs from TLR4-deficient (C3H/HeJ) mice to the lipid A fragment of the Bordetella pertussis LPS inhibits their activation by the Legionella lipid A. The data show selective action of different LPSs via different TLRs, and suggest that TLR2 can interact with many lipid A structures, leading to either agonistic or specific antagonistic effects.
引用
收藏
页码:293 / 302
页数:10
相关论文
共 51 条
  • [1] Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
    Aliprantis, AO
    Yang, RB
    Mark, MR
    Suggett, S
    Devaux, B
    Radolf, JD
    Klimpel, GR
    Godowski, P
    Zychlinsky, A
    [J]. SCIENCE, 1999, 285 (5428) : 736 - 739
  • [2] Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins
    Ancuta, P
    Pedron, T
    Girard, R
    Sandstrom, G
    Chaby, R
    [J]. INFECTION AND IMMUNITY, 1996, 64 (06) : 2041 - 2046
  • [3] A deacylase in Rhizobium leguminosarum membranes that cleaves the 3-O-linked β-hydroxymyristoyl moiety of lipid A precursors
    Basu, SS
    White, KA
    Que, NLS
    Raetz, CRH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) : 11150 - 11158
  • [4] Synergy between TLR2 and TLR4: A safety mechanism
    Beutler, E
    Gelbart, T
    West, C
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2001, 27 (04) : 728 - 730
  • [5] BHAT UR, 1994, J BIOL CHEM, V269, P14402
  • [6] INFLUENCE OF THE SUPRAMOLECULAR STRUCTURE OF FREE LIPID-A ON ITS BIOLOGICAL-ACTIVITY
    BRANDENBURG, K
    MAYER, H
    KOCH, MHJ
    WECKESSER, J
    RIETSCHEL, ET
    SEYDEL, U
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 218 (02): : 555 - 563
  • [7] Cooperation of toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein:: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling
    Bulut, Y
    Faure, E
    Thomas, L
    Equils, O
    Arditi, M
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (02) : 987 - 994
  • [8] Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide
    Flo, TH
    Halaas, O
    Lien, E
    Ryan, L
    Teti, G
    Golenbock, DT
    Sundan, A
    Espevik, T
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (04) : 2064 - 2069
  • [9] Gao JJ, 1999, J IMMUNOL, V163, P4095
  • [10] GIRARD R, 1993, J IMMUNOL, V150, P4504